Target intelligence / Profile preview

Bacterial flora of the skin lesion area

Molecular classification
Other
01

Overview

The bacterial flora of the skin lesion area are the various bacterial populations present in and around a skin lesion. Unlike a single molecular target, this term describes a complex microbial community. Its composition shifts in response to host factors (e.g., skin biogeography, immune status), lesion type, and environmental changes (wound, infection, treatment). The skin lesion flora may contain commensals (Staphylococcus epidermidis, Cutibacterium acnes, Corynebacterium spp.) and opportunistic or pathogenic species (e.g., Staphylococcus aureus, Streptococcus pyogenes, Pseudomonas aeruginosa). In healthy skin, such microbiota are protective, maintaining barrier function and competing against pathogens, but in lesions, dysbiosis (microbial imbalance) can contribute to or result from infection, impaired healing, inflammation, and disease progression. Therapeutic approaches increasingly target the skin microbiome as a community, using antibiotics, antiseptics, probiotic-based bacteriotherapies, and immunomodulators to re-balance flora and treat cutaneous diseases. However, "bacterial flora of the skin lesion area" is not a conventional molecule/receptor target, and thus the query refers to a microbial ecosystem rather than a single actionable entity.

Other names
skin microbiota of lesion areaskin lesion microbiomeskin flora of lesions
02

Mechanism of action

Not applicable as a molecular target. Drugs may act by: eradicating pathogenic bacteria (antibiotics, antiseptics); modifying overall microbial composition (probiotics, bacteriotherapy); or altering local immune environment (immunomodulatory therapies, UV phototherapy).

03

Biological functions

Other (acts as a community mediating colonization resistance, modulating local immune responses, and affecting wound healing)
04

Disease associations

InfectionInflammationOther (can contribute to or protect against skin disorders, infections, and inflammatory diseases depending on context)
05

Safety considerations

Dysbiosis (due to antibiotic therapy)Antibiotic resistanceImpaired skin healing (due to antibiotic therapy)Opportunistic infectionIncomplete safety profiles of live biotherapeutics
06

Interacting drugs

broad-spectrum antibiotics

3 more in the full profile.

07

Biomarkers

None directly; microbial sequencing and culture-based methods profile community diversity and pathogen abundance, but these are not specific molecular biomarkers

Beyond the preview

Go deeper on Bacterial flora of the skin lesion area.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial flora of the skin lesion area.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call